NCT00425165 Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease Status TERMINATED Phase PHASE2
NCT00424775 A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066) Status TERMINATED Phase PHASE1
NCT00424554 Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed) Status COMPLETED Phase PHASE2
NCT00424424 A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002) Status TERMINATED Phase PHASE2
NCT00423800 Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED) Status TERMINATED Phase PHASE3
NCT00423670 Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523) Status COMPLETED Phase PHASE2
NCT00423449 Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058) Status COMPLETED Phase PHASE1
NCT00423267 POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00423150 Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) Status TERMINATED Phase PHASE2
NCT00421278 The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00421148 Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961) Status COMPLETED Phase PHASE3
NCT00421018 Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK) Status COMPLETED Phase NA
NCT00420680 Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934) Status COMPLETED Phase PHASE3
NCT00420589 A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED) Status TERMINATED Phase PHASE3
NCT00420420 MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011) Status COMPLETED Phase PHASE2
NCT00419367 Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042) Status NO_LONGER_AVAILABLE Phase N/A
NCT00418613 A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED) Status COMPLETED Phase PHASE2